Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Yatim, Nader; Boussier, Jeremy; Tetu, Pauline; Smith, Nikaïa; Bruel, Timothée; Charbit, Bruno; Barnabei, Laura; Corneau, Aurélien; Da Meda, Laetitia; Allayous, Clara; Baroudjian, Barouyr; Jebali, Majdi; Herms, Florian; Grzelak, Ludivine; Staropoli, Isabelle; Calmettes, Vincent; Hadjadj, Jerome; Peyrony, Olivier; Cassius, Charles; LeGoff, Jerome; Kramkimel, Nora; Aractingi, Selim; Fontes, Magnus; Blanc, Catherine; Rieux-Laucat, Frederic; Schwartz, Olivier; Terrier, Benjamin; Duffy, Darragh; Lebbé, Celeste.
Afiliação
  • Yatim N; Translational Immunology Laboratory, Department of Immunology, Institut Pasteur, F-75015 Paris, France. celeste.lebbe@aphp.fr nader.yatim@aphp.fr.
  • Boussier J; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Tetu P; Sorbonne Université, AP-HP Hôpital Saint-Antoine, F-75012 Paris, France.
  • Smith N; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Bruel T; Translational Immunology Laboratory, Department of Immunology, Institut Pasteur, F-75015 Paris, France.
  • Charbit B; Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
  • Barnabei L; Vaccine Research Institute, Creteil, France.
  • Corneau A; Institut Pasteur, Cytometry and Biomarkers UTechS, CRT, F-75015 Paris, France.
  • Da Meda L; Université de Paris, Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, F-75015 Paris, France.
  • Allayous C; Sorbonne Université, Faculté de Médecine, UMS037, PASS, Plateforme de Cytométrie de la Pitié-Salpêtrière CyPS, F-75013 Paris, France.
  • Baroudjian B; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Jebali M; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Herms F; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Grzelak L; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Staropoli I; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Calmettes V; Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
  • Hadjadj J; Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
  • Peyrony O; Université de Paris, APHP Hopital Cochin, Department of Dermatology, Paris, France.
  • Cassius C; Université de Paris, Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, F-75015 Paris, France.
  • LeGoff J; Université de Paris, APHP Hopital Cochin, Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), F-75014 Paris, France.
  • Kramkimel N; APHP Hôpital Saint-Louis, Emergency Department, Paris, France.
  • Aractingi S; Université de Paris, APHP Hôpital Saint-Louis, Dermatology Department, DMU ICARE, INSERM U-976, Paris, France.
  • Fontes M; Université de Paris, INSERM, Equipe INSIGHT, U976, Virology, AP-HP, Hôpital Saint Louis, F-75010 Paris, France.
  • Blanc C; Université de Paris, APHP Hopital Cochin, Department of Dermatology, Paris, France.
  • Rieux-Laucat F; Université de Paris, APHP Hopital Cochin, Department of Dermatology, Paris, France.
  • Schwartz O; Institut Roche, Boulogne-Billancourt, France.
  • Terrier B; Sorbonne Université, Faculté de Médecine, UMS037, PASS, Plateforme de Cytométrie de la Pitié-Salpêtrière CyPS, F-75013 Paris, France.
  • Duffy D; Université de Paris, Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, F-75015 Paris, France.
  • Lebbé C; Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
Sci Adv ; 7(34)2021 08.
Article em En | MEDLINE | ID: mdl-34407944
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Linfócitos T / Inibidores de Checkpoint Imunológico / SARS-CoV-2 / COVID-19 / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Adv Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Linfócitos T / Inibidores de Checkpoint Imunológico / SARS-CoV-2 / COVID-19 / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Adv Ano de publicação: 2021 Tipo de documento: Article